ABOUT DEMYELINATING DISEASES
Conditions that result in damage to the myelin sheath in the central nervous system (CNS).
Demyelination may occur in one or a combination of specific areas in the CNS.
TRANSVERSE MYELITIS:(Spinal Cord)
MULTIPLE SCLEROSIS (MS):(Brain and Spinal Cord)
OPTIC NEURITIS:(Optic Nerve)
ODS:(Pontine Area of the Brain)
NEUROMYELITIS OPTICA:(Optic Nerve and Spinal Cord)
ACUTE DISSEMINATED ENCEPHALOMYELITIS:(Brain and Spinal Cord)
Symptoms vary greatly from disease to disease and person to person and may result in;
Physical and or cognitive impairment
Chronic progressive disability over years
One time event which may improve over time
Some types of demyelinating disorders occur when your immune system attacks your own tissues. But in many cases, doctors still aren’t certain what causes these conditions.
Current Treatments Focus On;
- Minimizing the effects of the attacks
- Slowing the course of the disease
- Managing symptoms
ENDECE Approach To Remyelination
ENDECE has discovered and is developing NDC-1308, a new therapy with a dual mechanism of action (MOA) designed to provide the necessary anti-inflammatory, pro-repair environment at lesions and upregulate genes necessary for inducing OPCs to differentiate into mature oligodendrocytes responsible for remyelination.
For more information see Developing NDC-1308
To learn more go to:
A new drug with a unique dual mechanism of action (MOA) for inducing remyelination, the process for restoring and repairing the myelin sheath in demyelinating diseases including multiple sclerosis, neuromyelitis optica, and osmotic demyelination syndrome.
To learn more go to Developing NDC-1308.
To request more information go to; ENDECE.com/contact